Parental experiences of consent for children with retinoblastoma undergoing ophthalmologic examinations under anesthesia

• Conditions: Parents of children aged 0-15 years who have been diagnosed with retinoblastoma and have undergone at least one eye examination under general anesthesia. The parents must be able to understand and communicate in Thai effectively, as the study will involve detailed interviews in this language. The parents must be willing to share their experiences and provide information for the study.; parents of pediatric patients with retinoblastoma who are receiving treatment at Srinakrin Hospital

• Registration Number: TCTR20240810006
• Lead Sponsor: Srinagarind Hospital, Faculty of Medicine, Khon Kaen University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-08-10
• Last Update Posted: 19 August 2024
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

In this study, the key informants are parents of pediatric patients with retinoblastoma who are receiving treatment at Srinakrin Hospital. The key informants meet the following criteria. Parents of children aged 0-15 years who have been diagnosed with retinoblastoma and have undergone at least one eye examination under general anesthesia. he parents must be able to understand and communicate in Thai effectively, as the study will involve detailed interviews in this language. The parents must be willing to share their experiences and provide information for the study.

Exclusion Criteria

the study are parents retinoblastoma and have undergone at least one eye examination or other procedures under general anesthesia. Individuals with neurological conditions neurodegenerative diseases Alzheimer or cognitive impairments that hinder their ability to make informed decisions or communicate effectively. Pregnant participants are excluded from the study to avoid additional complexities that may affect their participation.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the meanings and experiences of parents of pediatric patients with retinoblastoma in relation to consenting 45 min descriptive phenomenology

Secondary Outcome Measures

Name	Time	Method
experiences of parents of pediatric patients 45 min descriptive phenomenolog